Cargando…
A Novel Approach for Determining Cancer Genomic Breakpoints in the Presence of Normal DNA
CDKN2A (encodes p16(INK4A) and p14(ARF)) deletion, which results in both Rb and p53 inactivation, is the most common chromosomal anomaly in human cancers. To precisely map the deletion breakpoints is important to understanding the molecular mechanism of genomic rearrangement and may also be useful f...
Autores principales: | Liu, Yu-Tsueng, Carson, Dennis A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847701/ https://www.ncbi.nlm.nih.gov/pubmed/17440616 http://dx.doi.org/10.1371/journal.pone.0000380 |
Ejemplares similares
-
Tracking genome engineering outcome at individual DNA breakpoints
por: Certo, Michael T., et al.
Publicado: (2011) -
Recurrence of Chromosome Rearrangements and Reuse of DNA Breakpoints in the Evolution of the Triticeae Genomes
por: Li, Wanlong, et al.
Publicado: (2016) -
Translocation and deletion breakpoints in cancer genomes are associated with potential non-B DNA-forming sequences
por: Bacolla, Albino, et al.
Publicado: (2016) -
Cassis: detection of genomic rearrangement breakpoints
por: Baudet, Christian, et al.
Publicado: (2010) -
Determination of ETV6‐RUNX1 genomic breakpoint by next‐generation sequencing
por: Jin, Yanliang, et al.
Publicado: (2015)